What factors should be considered when formulating cannabinoid products for specific medical applications?
What factors should be considered when formulating cannabinoid products for specific medical applications? When formulating cannabinoid products for specific medical applications, factors such as cannabinoid composition, delivery method, dosing, and patient population should be carefully considered. The specific therapeutic target will influence the choice of cannabinoids (e.g., THC vs. CBD) and their ratios, as different cannabinoids may exert distinct effects. Additionally, the formulation should consider the intended route of administration, which can impact bioavailability and patient compliance. Patient characteristics, including age, comorbidities, and preferences, also play a crucial role in tailoring cannabinoid products. By considering these factors, manufacturers can develop effective and patient-centered cannabinoid therapies (Wilkinson et al., 2020).
